Optimization of nanoparticles for cardiovascular tissue engineering

Nanotechnology

Volumn 26, Issue 23, 2015, Pages

  Izadifar, Mohammad ^a,c   Kelly, Michael E ^a,b,c   Haddadi, Azita ^a   Chen, Xiongbiao ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

Cardiovascular; Controlled release; Delivery systems; Nanoparticles; Tissue engineering

Indexed keywords

CIRCULAR DICHROISM SPECTROSCOPY; DICHROISM; FABRICATION; MOLECULAR WEIGHT; NANOPARTICLES; TISSUE; TISSUE REGENERATION; VOLCANIC ROCKS; ZETA POTENTIAL;

CARDIOVASCULAR; CARDIOVASCULAR TISSUE ENGINEERING; CENTRAL COMPOSITE ROTATABLE DESIGN; CONTROLLED RELEASE; DELIVERY SYSTEMS; ELECTRON MICROSCOPY IMAGES; NEGATIVE ZETA POTENTIALS; POLY LACTIDE-CO-GLYCOLIDE;

TISSUE ENGINEERING;

LACTIC ACID; NANOPARTICLE; OVALBUMIN; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTIFICIAL NEURAL NETWORK; CARDIOVASCULAR FUNCTION; DEVICES; DRUG DELIVERY SYSTEM; MATERIALS TESTING; PARTICLE SIZE; PROCEDURES; SURFACE PROPERTY; TISSUE ENGINEERING; ULTRASTRUCTURE;

CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; DRUG DELIVERY SYSTEMS; LACTIC ACID; MATERIALS TESTING; NANOPARTICLES; NEURAL NETWORKS (COMPUTER); OVALBUMIN; PARTICLE SIZE; POLYGLYCOLIC ACID; SURFACE PROPERTIES; TISSUE ENGINEERING;

EID: 84930010657     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/26/23/235301     Document Type: Article

References (35)

1. Izadifar M, Kelly E M and Chen X B 2014 Engineering angiogenesis for myocardial infarction repair: recent developments, challenges, and future directions Cardiovasc. Eng. Technol. 5 281-307
2. Izadifar M, Haddadi A, Chen X B and Kelly M E 2014 Rate-programming of nano-particulate delivery systems for smart scaffolds in tissue engineering Nanotechnology 26 012001
3. Zhang S F and Uludag H 2009 Nanoparticulate systems for growth factor delivery Pharm. Res. 26 1561-80
4. Danhier F, Ansorena E, Silva J M, Coco R, Le-Breton A and Préat V 2012 PLGA-based nanoparticles: an overview of biomedical applications J. Control. Release 161 505-22
5. Shin S H, Lee J, Lim K S, Rhim T, Lee S K, Kim Y H and Lee K Y 2013 Sequential delivery of TAT-HSP27 and VEGF using microsphere/hydrogel hybrid systems for therapeutic angiogenesis J. Control. Release 166 38-45
6. Formiga F R et al 2010 Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model J. Control. Release 147 30-7
7. Golub J S, Kim Y T, Duvall C L, Bellamkonda R V, Gupta D, Lin A S, Weiss D, Robert Taylor W and Guldberg R E 2010 Sustained VEGF delivery via PLGA nanoparticles promotes vascular growth Am. J. Physiol. Heart Circ. Physiol. 298 H1959-65
8. Geng H, Song H, Qi J and Cui D 2011 Sustained release of VEGF from PLGA nanoparticles embedded thermo-sensitive hydrogel in full-thickness porcine bladder acellular matrix Nanoscale Res. Lett. 6 312
9. Simón-Yarza T, Tamayo E, Benavides C, Lana H, Formiga F R, Grama C N, Ortiz-de-Solorzano C, Kumar M N, Prosper F and Blanco-Prieto M J 2013 Functional benefits of PLGA particulates carrying VEGF and CoQ10 in an animal of myocardial ischemia Int. J. Pharm. 454 784-90
10. Wang Y, Cooke M J, Sachewsky N, Morshead C M and Shoichet M S 2013 Bioengineered sequential growth factor delivery stimulates brain tissue regeneration after stroke J. Control. Release 172 1-11
11. Lamprecht A, Ubrich N, Hombreiro Pérez M, Lehr C M, Hoffman M and Maincent P 1999 Biodegradable monodispersed nanoparticles prepared by pressure homogenization-mulsification Int. J. Pharm. 184 97-105
12. Lamprecht A, Ubrich N, Hombreiro Pérez M, Lehr C M, Hoffman M and Maincent P 2000 Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique Int. J. Pharm. 196 177-82
13. Berchane N S, Carson K H, Rice-Ficht A C and Andrews M J 2007 Effect of mean diameter and polydispersity of PLG microspheres on drug release: Experiment and theory Int. J. Pharm. 337 118-26
14. Jimenez N, Galan J, Vallet A, Egea M A and Garcia M L 2010 Methyl trypsin loaded poly(d,l-lactide-coglycolide) nanoparticies for contact lens care J. Pharm. Sci. 99 1414-26
15. Igartua M, Hernández R M, Esquisabel A, Gascón A R, Calvo M B and Pedraz J L 1998 Stability of BSA encapsulated into PLGA microspheres using PAGE and capillary electrophoresis Int. J. Pharm. 169 45-54
16. Kang F and Singh J 2003 Conformational stability of a model protein (bovine serum albumin) during primary emulsification process of PLGA microspheres synthesis Int. J. Pharm. 260 149-56
17. Bilati U, Allemann E and Doelker E 2005 Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles Eur. J. Pharm. Biopharm. 59 375-88
18. Feczkó T, Tótha J, Dósac G and Gyenis J 2011 Optimization of protein encapsulation in PLGA nanoparticles Chem. Eng. Process. 50 757-65
19. Zhou Y Z, Alany R G, Chuang V and Wen J 2013 Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design Drug Dev. Ind. Pharm. 39 321-30
20. Panyam J, Dali M M, Sahoo S K W M, Chakravarthi S S, Amidon G L, Levy R J and Labhasetwar V 2003 Polymer degradation and in vitro release of a model protein from poly(d,l-lactide-co-glycolide) nano- and microparticles J. Control. Release 92 173-87
21. Montgomery D C 1996 Design and Analysis of Experiments (New York: Wiley) ISBN13: 978-1118146927
22. Sahu J N, Acharya J and Meikap B C 2009 Response surface modeling and optimization of chromium (VI) removal from aqueous solution using tamarind wood activated carbon in batch process J. Hazard. Mater. 172 818-25
23. Özer A, Gürbüz G, Çalml A and Körbahti B K 2009 Biosorption of copper(II) ions on Enteromorpha prolifera: application of response surface methodology (RSM) Chem. Eng. J. 146 377-87
24. Moghaddam S S, Alavi Moghaddam M R and Arami M 2010 Coagulation/flocculation process for dye removal using sludge from water treatment plant: optimization through response surface methodology J. Hazard. Mater. 175 651-7
25. Myers R H and Montgomery D C 2002 Response Surface Methodology: Process and Product Optimization using Designed Experiments (New York: Wiley) ISBN: 978-0-470-17446-3
26. Izadifar M 2005 Neural network modeling of trans isomer formation and unsaturated fatty acid changes during oil hydrogenation J. Food Eng. 66 227-32
27. Izadifar M and Abdolahi F 2006 Comparison between neural network and mathematical modeling of supercritical CO2 extraction of black pepper essential oil J. Supercrit. Fluids 38 37-43
28. D'Souza S S, Faraj J A and DeLuca P P 2005 A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres AAPS Pharm. Sci. Technol. 6 E553-64
29. Wang J, Wang B M and Schwendeman S P 2002 Characterization of the initial burst release of a model peptide from poly(d,l-lactide-co-glycolide) microspheres J. Control. Release 82 289-307
30. Budhian A, Siegel S J and Winey K I 2007 Haloperiodol-loaded PLGA nanoparticles: systemic study of particle size and drug content Int. J. Pharm. 336 367-75
31. Redhead H M, Davis S S and Illum L 2001 Drug delivery in poly (lactide-co-glycolide) nanoparticles surface modified with copoloxamer 407 and poloxamine 908: in vitro characterization and in vivo evaluation J. Control. Release 70 353-63
32. Stolnik S et al 1995 The colloidal properties of surfactant-free biodegradable nanospheres from poly (b-malic acid-co-benzyl malate)s and poly (lactic acid- co-glycolide) Colloids Surf. 97 235-45
33. Zhao A and Rodgers V G J 2006 Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles J. Control. Release 113 15-22
34. Perkins S J, Smith K F, Nealis A S, Haris P I, Chapman D, Bauer C J and Harrison R A 1992 Secondary structure changes stabilize the reactive-centre cleaved form of SERPINs. A study by 1H nuclear magnetic resonance and Fourier transform infrared spectroscopy J. Mol. Biol. 228 1235-54
35. Koseki T, Kitabatake N and Doi E 1988 Conformational changes in ovalbumin at acid pH J. Biochem. 103 425-30